TherapeuticsMD (TXMD) Amortizatization of Intangibles (2011 - 2013)
TherapeuticsMD (TXMD) posted Amortizatization of Intangibles of $1.1 million for Q1 2013, up 147.87% on a QoQ basis from $444865.0 in Q4 2012, and up 1969.13% year-over-year from $53292.0 in Q1 2012.
TherapeuticsMD (TXMD) Amortizatization of Intangibles (2011 - 2013) Analysis & Trends
TherapeuticsMD's Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at $1.1 million for Q1 2013.
- Quarterly Amortizatization of Intangibles rose 1969.13% year-over-year to $1.1 million in Q1 2013, while the trailing twelve-month figure through Dec 2013 was $1.1 million (down 31.26% YoY) and the FY2013 annual result came in at $1.1 million, down 31.26% from the prior year.
- Amortizatization of Intangibles was $1.1 million for Q1 2013 at TherapeuticsMD, up from $444865.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $1.1 million in Q1 2013 and bottomed at $3590.0 in Q2 2011.
- A 3-year average of $341954.9 and a median of $51695.5 in 2012 frame the typical range for Amortizatization of Intangibles.
- Peak annual rise in Amortizatization of Intangibles reached 29314.6% in 2012, while the deepest fall reached 248.88% in 2012.
- TherapeuticsMD's Amortizatization of Intangibles stood at $10769.0 in 2011, then jumped by 4030.98% to $444865.0 in 2012, then jumped by 147.87% to $1.1 million in 2013.
- Business Quant data shows TXMD's Amortizatization of Intangibles at $1.1 million in Q1 2013, $444865.0 in Q4 2012, and $50099.0 in Q3 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1.30 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | TherapeuticsMD | 280,418.39 | -8.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | 1.10 Mn |
| Mar 31, 2013 | 1.10 Mn |
| Dec 31, 2012 | 444,865.00 |
| Dec 31, 2012 | 444,865.00 |
| Sep 30, 2012 | 50,099.00 |
| Sep 30, 2012 | 50,099.00 |
| Jun 30, 2012 | 1.06 Mn |
| Jun 30, 2012 | 1.06 Mn |
| Mar 31, 2012 | 53,292.00 |
| Mar 31, 2012 | 53,292.00 |
| Dec 31, 2011 | 10,769.00 |
| Dec 31, 2011 | 10,769.00 |
| Sep 30, 2011 | 14,360.00 |
| Sep 30, 2011 | 14,360.00 |
| Jun 30, 2011 | 3,590.00 |
| Jun 30, 2011 | 3,590.00 |